MITO CERV 2
Trial Description:
Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Cervical
Trial Status:
Completed
Contact person:
spignata